A Randomized Controlled Trial of Probiotics Targeting Gut Dysbiosis in Huntington’s Disease

Abstract

Despite the lack of probiotic effects in this trial, the potential utility of the gut as a therapeutic target in HD should continue to be explored given the clinical symptomology, gut dysbiosis, and positive results from probiotics and other gut interventions in similar neurodegenerative diseases.